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Abstract
Background:  Gangliocytic paraganglioma are rare neoplasms that predominantly arise in
periampulary region. Though considered benign the disease can spread to regional lymphatics.
Case presentation: A 49 year old woman presented with melena and was found to have a
periampullary mass. Endoscopic evaluation and biopsy demonstrated a periampullary
paraganglioma. The tumor was resected with pylorus-preserving pancreaticoduodenectomy and
was found to represent a gangliocytic paraganglioma associated with nodal metastases. In a
controversial decision, the patient was treated with adjuvant external beam radiation therapy. She
is alive and well one year following resection. The authors have reviewed the current literature
pertaining to this entity and have discussed the biologic behavior of the tumor as well as the
rationale for treatment strategies employed.
Conclusion: Paraganglioma is a rare tumor that typically resides in the gastrointestinal tract and
demonstrates low malignant potential. Due to rarity of the disease there is no consensus on the
adjuvant treatment even though nearly 5% of the lesions demonstrate the malignant potential.
Background
Gangliocytic paragangliomas are unusual neoplasms that
may be identified anywhere within the gastrointestinal
tract, but predominate in the periampullary region. This
entity was first discussed by Dahl et al in 1957, and subse-
quently reported by Taylor and Helwig in 1962 [1,2].
Kepes and Zacharias named the tumor and described its
characteristics in 1971 [3]. The pathognomonic features
of these neoplasm is the identification of three distinct
cellular elements: spindle cells, epithelial cells, and gan-
glion cells. These tumors are considered benign, yet occa-
sionally metastasize to regional lymph nodes, as well as to
distant organs [4]. Long term survival is common with
appropriate resection. We report a case of a 49-year-old
female who presented with melena and was found to have
a periampullary gangliocytic duodenal paraganglioma.
The details of the clinical presentation, histopathological
findings, and therapeutic choices are provided.
Case presentation
A 49-year-old woman presented with a 6-month history
of melena. During the preliminary consultation, she also
complained of right upper quadrant pain, which radiated
to her right lower quadrant and upper back. She
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underwent upper gastrointestinal (GI) endoscopy which
demonstrated a 3 cm, ulcerated, ampullary mass (figure
1). Endoscopic biopsies suggested the diagnosis of para-
ganglioma. The lesion did not obstruct the ampullary ori-
fice. Both computed tomography (CT) and magnetic
resonance imaging (MRI) of the abdomen failed to dem-
onstrate this lesion or any additional abnormalities.
The patient underwent pylorus-preserving pancreaticodu-
odenectomy and lymph node dissection. The postopera-
tive course was uneventful except for delayed gastric
emptying diagnosed by frequent vomiting during postop-
erative days 7 to 10, and confirmed by gastrograffin swal-
low. These symptoms eventually resolved with
conservative management and the patient was discharged
from the hospital on 15th postoperative day.
Histopathological analysis
Gross pathological evaluation of the resected specimen
included a portion of duodenum with ampulla, measur-
ing 16 cm. in length, and a portion of pancreatic head
measuring 5 cm. in length. There was a polypoid periam-
pullary mass protruding into the duodenal lumen, meas-
uring 1.4 × 1.2 × 0.7 cm. On cut section, the mass was
moderately firm and pink-tan. It was circumscribed but
unencapsulated, and appeared to be covered by normal
appearing duodenal mucosa. There was no evidence of
pancreatic invasion by the tumor. A total of seven lymph
nodes were also removed, 5 peripancreatic (3.0 cm in
greatest dimension) and 2 periduodenal (1.2 cm and 1.0
cm in greatest dimension, respectively).
Histologically, the tumor consisted of a complex neoplas-
tic proliferation that included a component resembling
carcinoid or islet cell tumor (figure 2), admixed with a
proliferation of spindled neurofibrillary cells and larger
polygonal cells demonstrating gangliocytic differentiation
(figures 3 and 4). There were areas of stromal hyaliniza-
tion resembling amyloid, with focal calcification (figure
5). Congo red and Thioflavin T stains were negative for
amyloid. The tumor extended through the muscularis pro-
pria and along the common bile duct, but did not invade
the pancreas. The resection margins were free of tumor.
Metastatic paraganglioma was present in 6 of 7 periduo-
denal and peripancreatic lymph nodes. The metastatic
lymph nodes showed the same mixed histologic features
as the primary tumor.
Immunohistochemical analysis demonstrated that the
tumor stained positively for S-100, chromogranin, synap-
tophysin, and cytokeratin AE1 and AE3. No reactivity was
observed with MART-1 or HMB 45. Staining for c-kit (CD
117) was performed on sections of the primary tumor and
of one of the lymph nodes with metastatic tumor. The car-
cinoid-like epithelial cells and the spindle-shaped neu-
rofibrillar cells stained negatively for the cell marker c-Kit.
The gangliocytic cells stained strongly positive for c-kit.
Adjuvant therapy
Due to the evidence of regional lymph node metastasis
the patient was counseled regarding adjuvant therapeutic
options. The treating physicians queried recognized
Endoscopic photograph of the paraganglioma demonstrating  an exophytic tumor whose edges enfold around a central  area of necrosis that is actively bleeding Figure 1
Endoscopic photograph of the paraganglioma demonstrating 
an exophytic tumor whose edges enfold around a central 
area of necrosis that is actively bleeding. Photomicrograph showing areas of the tumor that had an  epithelial pattern resembling carcinoid tumor or islet cell  tumor Figure 2
Photomicrograph showing areas of the tumor that had an 
epithelial pattern resembling carcinoid tumor or islet cell 
tumor. These cells were cohesive, uniform in size and shape 
with small round uniform nuclei, and formed rosettes, cribri-
form structures, solid nests and trabecular cords (Hematox-
ylin and Eosin original magnification ×100).World Journal of Surgical Oncology 2005, 3:15 http://www.wjso.com/content/3/1/15
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experts in the field of radiation therapy for gastrointesti-
nal malignancies via email and a consensus developed
that external beam radiation therapy might be reasonable,
although it was admitted that no data are available regard-
ing the use of this modality for this disease entity. Ulti-
mately, a decision was made to administer external beam
radiotherapy to the abdomen in an effort to eradicate any
possible residual disease not removed during surgery and
to reduce the risk of locally recurrent disease. No chemo-
therapy was advised due to the rarity of distant metastases
and the lack of response of these neoplasms to conven-
tional systemic therapy.
The patient was treated with intensity-modulated radio-
therapy in 28 fractions of 180 cGy/fraction over 37
elapsed days; 6 mv photon beam energy was used. The tar-
get was a postoperative tumor bed with a 5–10 mm mar-
gin. The total dose was 5,040 cGy. She tolerated treatment
well and is now symptom free more than one year follow-
ing resection. Surveillance CT scans and endoscopy have
been performed both of which reveal no evidence of
recurrent disease.
Discussion
Gangliocytic paraganglioma is a rare, typically benign
tumor of the gastrointestinal tract most commonly
located in the second portion of the duodenum, with a
few cases having involved the jejunum and pylorus [5-7].
Burke et al reported that there seems to be a slight male
predominance and an average age of 54 at presentation
[5]. Other authors have denied that there is any gender
preference [8]. This lesion usually presents with abdomi-
nal pain and gastrointestinal bleeding due to mucosal
ulceration. Obstructive jaundice is less common [9].
Photomicrograph showing areas of the tumor that consisted  of a proliferation of spindled neurofibrillary cells with  admixed larger polygonal ganglionic cells (Hematoxylin and  Eosin original magnification ×100) Figure 3
Photomicrograph showing areas of the tumor that consisted 
of a proliferation of spindled neurofibrillary cells with 
admixed larger polygonal ganglionic cells (Hematoxylin and 
Eosin original magnification ×100).
Photomicrograph showing the ganglionic cells having large  round nuclei with chromatin clearing and large central  nucleoli Figure 4
Photomicrograph showing the ganglionic cells having large 
round nuclei with chromatin clearing and large central nucle-
oli. The cytoplasm is abundant and amphophilic staining. The 
ganglionic cells are admixed with the spindled cells (Hema-
toxylin and Eosin original magnification ×400).
Photomicrograph showing the focal areas of stromal hyalini- zation with calcification Figure 5
Photomicrograph showing the focal areas of stromal hyalini-
zation with calcification. Special stains for amyloid were nega-
tive (Hematoxylin and Eosin original magnification ×200).World Journal of Surgical Oncology 2005, 3:15 http://www.wjso.com/content/3/1/15
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Histologically, our patient's tumor demonstrated the
characteristic tricellular pattern of gangliocytic paragangli-
omas. These tumors are typically composed of an admix-
ture of ganglion cells, spindle cells and epithelial cells
[5,10-13]. These tumors are submucosal, and rarely recur
or metastasize [14-16]. In most reported cases regional
lymph node involvement, the metastatic cells consist pre-
dominantly of epithelial cells [15]. A relatively unique ele-
ment of the case we present is that six of 7 regional lymph
node metastases contained all three characteristic cell
types, and thus, demonstrated the possibility for each of
these cell types to acquire a malignant potential.
Immunohistochemically these tumors stain positive for a
variety of markers as was demonstrated in this report.
Such markers include those mentioned above as well as
neuron-specific enolase, pancreatic polypeptide, somato-
statin, myelin basic protein and neurofilament proteins
[6,12,13,17]. The origin of gangliocytic paragangliomas
has been widely debated and includes hypotheses ranging
from a hamartomatous derivation to cellular elements
arising from pancreatic neuroendocrine tissue, or that of
the retroperitoneal celiac sympathetic or parasympathetic
plexuses [4,12].
There is no data in the literature to guide clinicians on the
use of adjuvant therapy despite the fact that approxi-
mately 5% of cases demonstrate malignant features [4].
Since this patient had multiple positive lymph nodes and
is relatively young, a trial of adjuvant radiotherapy to the
operative bed was considered reasonable and was
endorsed by radiation oncologists at high volume cancer
centers queried via email.
Conclusion
Gangliocytic paraganglioma is a rare duodenal tumor that
can present with non-specific symptoms. Positive diagno-
sis can be obtained histologically by observing three char-
acteristic cell types. Although this tumor is considered
benign, the possibility exists for regional lymph nodal
spread. Due to the rarity of the disease, no clear adjuvant
treatment strategy has been determined in cases that dem-
onstrate regional or distant metastasis.
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